Literature DB >> 26205635

Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis.

Shahamat Tauhid1, Renxin Chu1, Rahul Sasane2, Bonnie I Glanz1, Mohit Neema1, Jennifer R Miller1, Gloria Kim1, James E Signorovitch3, Brian C Healy1, Tanuja Chitnis1, Howard L Weiner1, Rohit Bakshi4,5,6.   

Abstract

Multiple sclerosis (MS) commonly affects occupational function. We investigated the link between brain MRI and employment status. Patients with MS (n = 100) completed a Work Productivity and Activity Impairment (WPAI) (general health version) survey measuring employment status, absenteeism, presenteeism, and overall work and daily activity impairment. Patients "working for pay" were considered employed; "temporarily not working but looking for work," "not working or looking for work due to age," and "not working or looking for work due to disability" were considered not employed. Brain MRI T1 hypointense (T1LV) and T2 hyperintense (T2LV) lesion volumes were quantified. To assess lesional destructive capability, we calculated each subject's ratio of T1LV to T2LV (T1/T2). Normalized brain parenchymal volume (BPV) assessed brain atrophy. The mean (SD) age was 45.5 (9.7) years; disease duration was 12.1 (8.1) years; 75 % were women, 76 % were relapsing-remitting, and 76 % were employed. T1LV, T1/T2, Expanded Disability Status Scale (EDSS) scores, and activity impairment were lower and BPV was higher in the employed vs. not employed group (Wilcoxon tests, p < 0.05). Age, disease duration, MS clinical subtype, and T2LV did not differ between groups (p > 0.05). In multivariable logistic regression modeling, adjusting for age, sex, and disease duration, higher T1LV predicted a lower chance of employment (p < 0.05). Pearson correlations showed that EDSS was associated with activity impairment (p < 0.05). Disease duration, age, and MRI measures were not correlated with activity impairment or other WPAI outcomes (p > 0.05). We report a link between brain atrophy and lesions, particularly lesions with destructive potential, to MS employment status.

Entities:  

Keywords:  Brain atrophy; Brain lesions; Disability; Employment; MRI; Multiple sclerosis; Productivity

Mesh:

Year:  2015        PMID: 26205635      PMCID: PMC4639581          DOI: 10.1007/s00415-015-7853-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


Introduction

The compromised ability to perform occupational function and unemployment is commonly seen in multiple sclerosis (MS) [1-8]. Impaired work performance is related to a variety of disease manifestations including physical disability, cognitive impairment, psychological factors, pain, and fatigue [1–4, 6–13]. Furthermore, in addition to the financial impact of occupational limitations, such impairment may significantly lower quality of life [2, 14]. MRI of the brain is a valuable tool for the diagnosis and longitudinal monitoring of patients with MS [15]. MRI imaging can depict a variety of effects of the disease process, such as the development of T1 hypointense lesions, T2 hyperintense lesions, and atrophy [15, 16]. A growing body of evidence has linked MRI-defined disease severity to key clinical manifestations such as physical disability, mood disturbances, and cognitive impairment [15-24]. However, to date, the relationship between MRI and occupational function has not been evaluated. In a recent cross-sectional study, we administered a work productivity scale to patients with MS and identified a role for disability, depression, fatigue, and anxiety in impairment of occupational functions [2]. In the present study, we extended our previous observations in this cohort by examining the available MRI scans to assess the link between brain lesions/atrophy and employment status/productivity.

Methods

Subjects and clinical evaluation

As part of the Comprehensive Longitudinal Investigation of Multiple Sclerosis at Brigham and Women’s Hospital (CLIMB) study [25], we previously reported employment-related data on 377 patients with a clinically isolated demyelinating syndrome (CIS) or relapsing-remitting MS (RRMS), based on the administration of the Work Productivity and Activity Impairment (WPAI) questionnaire (general health version) [2]. The WPAI survey, administered during a scheduled clinical visit in the CLIMB study, measured employment status, absenteeism, presenteeism (impairment during work), overall work impairment, and daily activity impairment. Patients who reported “working for pay” were classified as employed (n = 76). While those “temporarily not working but looking for work,” “not working or looking for work due to age,” and “not working or looking for work due to disability” were considered not employed (n = 16). Patients who were not classified as employed or not employed (n = 8) because they were working in home (n = 4), volunteering (n = 1), or in school (n = 3) were excluded from the analysis comparing the employed vs. not employed groups. During the same clinical visit, patients also underwent a neurologic examination by an MS neurologist to rate physical disability using the Expanded Disability Status Scale (EDSS) [26]. To qualify for this MRI-based sub-study, patients were required to have undergone brain imaging on the assigned CLIMB study MRI scanner using a consistent acquisition protocol that included a 3D high-resolution scan and was performed within 90 days of the clinical visit. One hundred patients were identified, the clinical and demographic characteristics of whom are shown in Table 1.
Table 1

Multiple sclerosis patient characteristics

Age, years: Mean ± SD (range)45.5 ± 9.7 (19.9–64.8)
Female, n (%)75 (75.0)
Race, n (%)
 Black or African American4 (4.0)
 South Asian1 (1.0)
 White94 (94.0)
 Unknown1 (1.0)
 Employment status, n (%)
 Working for pay76 (76.0)
 Working in home4 (4.0)
 Volunteering1 (1.0)
 In school3 (3.0)
 Temporarily not working but looking for work3 (3.0)
 Not working or looking for work because of age2 (2.0)
 Not working or looking for work because of disability11 (11.0)
 MS disease duration, years: Mean ± SD (range)12.1 ± 8.1 (1.6–36.6)
MS category, n (%)
 Clinically isolated syndrome6 (6.0)
 Relapsing-remitting76 (76.0)
 Secondary progressive12 (12.0)
 Primary progressive6 (6.0)
Brain parenchymal volume, mL: Mean ± SD (range)1429.7 ± 70.7 (1216.3–1574.7)
T1 hypointense lesion volume, mL: Mean ± SD (range)1.3 ± 2.1 (0.0–9.5)
T2 hyperintense lesion volume, mL: Mean ± SD (range)4.9 ± 6.7 (0.1–28.3)
T1/T2 lesion volume ratio: Mean ± SD (range)0.3 ± 0.2 (0.0–0.7)
EDSS: Mean ± SD (range)2.2 ± 1.9 (0.0–7.5)
WPAI:GH, mean ± SD,  %
 Activity impairment (n = 99)21.0 ± 26.5
 Overall work impairment (n = 74)18.3 ± 25.6
 Absenteeism (i.e., percent work time missed, n = 74)6.7 ± 19.7
 Presenteeism (i.e., days at work but limited in performing job tasks due to health, n = 72)13.5 ± 20.1

n = 100 unless otherwise indicated

EDSS expanded disability status scale, WPAI:GH work productivity and activity impairment-general health

Multiple sclerosis patient characteristics n = 100 unless otherwise indicated EDSS expanded disability status scale, WPAI:GH work productivity and activity impairment-general health All subjects gave informed consent. This study was approved by the Partners Health Care ethics committee and was performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments.

MRI acquisition

Brain MRI was performed in all subjects on a 1.5T scanner (GE Signa, Milwaukee, WI). Scan acquisitions covered the whole brain and included an axial T1-weighted spin-echo (TR/TE: 725/20 ms) and dual-echo T2-weighted (TR/TE2/TE1: 3000/80/30 ms) series (voxel size 0.94 × 0.94 × 3 mm) and a sagittal 3D MP-RAGE sequence (TR/TE: 8.6/3.8 ms) with a voxel size of 0.94 × 0.94 × 1.2 mm. T1-weighted spin-echo imaging was repeated 5 min after 0.1 mol/kg intravenous gadolinium (Gd).

MRI analysis: lesions

Brain T1 hypointense (T1LV) and T2 hyperintense lesion volume (T2LV) were expert-quantified with an edge-finding tool using Jim software (v.5, Xinapse Systems Ltd, West Bergholt, UK, http://www.xinapse.com/). T2 hyperintense lesions were defined as those showing hyperintensity on both the proton density and late echo T2-weighted images. T1 hypointense lesions (“black holes”) were required to show at least partial hyperintensity on the dual-echo images, but no gadolinium-enhancement (to reduce the likelihood of including transient lesions) [15]. To assess a patient’s lesional destructive capability, we calculated the ratio of T1LV to T2LV (T1/T2) for each subject, based on our previous work showing the value of this metric [27-29].

MRI analysis: atrophy

To assess whole brain atrophy, we measured normalized brain parenchymal volume (BPV) from the 3D MP-RAGE images using the fully automated segmentation-based algorithm, Structural Image Evaluation using Normalization of Atrophy (SIENAX) [30]. Our method has been previously detailed [31]. Briefly, the automated process involved extraction of the brain and CSF volume from the whole-head input data, followed by affine-registration to a standardized space. The volumetric scaling factor was then obtained for normalization by head size. Tissue-type segmentation with partial volume estimation was then conducted to calculate the total volume of brain tissue vs. CSF. Optimization experiments led to our use of the default brain extraction threshold of 0.5 to maintain adequate segmentation in each image set.

Statistical analysis

Baseline descriptive statistics were summarized, and baseline age, disease duration, EDSS, brain volume measures, and activity impairment were compared between employed vs. not employed patients using the Wilcoxon rank-sum test. Correlations between patient characteristics and WPAI General Health scores were assessed using Pearson’s correlation coefficient for all variables except for EDSS, for which the associations were measured using Spearman’s rho. Logistic regression models were used to explore whether employment status was associated with brain volume and lesion volume. Age, sex, and disease duration were included as covariates in the logistic regression models. All data analyses were performed using SAS release 9.3 (SAS Institute, Inc., Cary, NC).

Results

Patient demographic, clinical, and MRI characteristics are shown in Table 1. Among the 100 patients analyzed in the correlation analysis, 74 % had absenteeism and 72 % had presenteeism data. A total of 12 patients had an absenteeism score >0, while 33 patients had a presenteeism score >0. The main results are shown in Tables 2 and 3 and Figs. 1, 2, 3, 4. Seven patients had Gd-enhanced lesions; however, due to power considerations and study design, we did not formally compare patients for the presence or absence of Gd-enhancing lesions in relation to employment in this study. As shown in Table 2 and Figs. 1, 2, and 4, T1LV, T1/T2, Expanded Disability Status Scale (EDSS) scores, and activity impairment were lower and BPV was higher in the employed vs. not employed group (Wilcoxon tests, p < 0.05; Wilcoxon rank-sum tests, p < 0.05). Age, disease duration, T2LV, and clinical subtype of MS were not significantly different between groups (p > 0.05) (Tables 2 and 3, Fig. 3). Spearman’s correlation coefficient showed that EDSS was associated with activity impairment (p < 0.05) (Table 4). However, disease duration, age, and MRI variables were not correlated with activity impairment, absenteeism, presenteeism, or overall work impairment (all p > 0.05).
Table 2

Clinical/MRI multiple sclerosis disease variables in employed vs. not employed patients

Mean difference employed (n = 76) vs. not employed (n = 16)Wilcoxon rank-sum test p valueb
Patient characteristicsa
 Agec −4.4290.090
 Disease duration−0.0080.857
 Baseline EDSS−2.030<0.001
Brain volume measuresa
 BPV3.6450.036
 T1LV−1.2880.014
 T2LV−1.7390.107
 T1/T2 LV ratio−0.0930.012
Activity Impairment−27.1250.002

EDSS Expanded Disability Status Scale score, BPV brain parenchymal volume, LV lesion volume

aThis analysis was conducted among patients who reported any of the following: “working for pay,” “temporarily not working but looking for work,” not working or looking for work due to age,” and “not working or looking for work due to disability.” Patients who reported “working for pay” were considered employed. BPV, T1, and T2 lesion volumes are measured in mL

b p values were estimated using a non-parametric Wilcoxon rank-sum test for two independent samples

cWhen stratified by employment status, the mean age among employed patients was 44.9 (SD 8.6) with a range of 27.1–62.6 years and the mean age among not employed patients was 49.3 (SD 10.5) with a range of 29.8–64.8 years. Note that the regression modeling testing the relationships between MRI and employment status were adjusted for age, sex, and disease duration (see “Results” Section)

Table 3

Clinical subtype of multiple sclerosis by employment status

Employed, n (%)Not employed, n (%)
Clinically isolated syndrome5 (6.6)1 (6.3)
Relapsing-remitting60 (78.9)10 (62.5)
Secondary progressive6 (7.9)4 (25.0)
Primary progressive5 (6.6)1 (6.3)

There was no significant difference between employed (n = 76) and not employed (n = 16) groups in terms of the distribution of multiple sclerosis clinical subtype (p > 0.05)

Fig. 1

Brain atrophy is associated with MS employment status. Boxplot with mean (diamond), median, quartiles, 95 % interval whiskers and outliers. Wilcoxon rank-sum test: p value = 0.036

Fig. 2

Brain T1 hypointense lesion volume is associated with MS employment status. Boxplot with mean (diamond), median, quartiles, 95 % interval whiskers and outliers. Wilcoxon rank-sum test: p value = 0.014

Fig. 3

Brain T2 hyperintense lesion volume is not associated with MS employment status. Boxplot with mean (diamond), median, quartiles, 95 % interval whiskers and outliers. Wilcoxon rank-sum test: p value = 0.107

Fig. 4

Brain T1/T2 lesion volume ratio is associated with MS employment status. Boxplot with mean (diamond), median, quartiles, 95 % interval whiskers and outliers. Wilcoxon rank-sum test: p value = 0.012

Table 4

Correlations between clinical/MRI multiple sclerosis disease variables and work productivity

VariablesPatient characteristics (years)Physical disabilityWork Productivity and Activity Impairment-General Health (%)Brain volume measures
AgeDisease durationEDSSActivity impairmentOverall work impairmentAbsenteeismPresenteeismBPVT1 lesion volumeT2 lesion volumeT1/T2 lesion volume ratio
BPV−0.370*−0.199*−0.219*−0.150−0.112−0.018−0.132−0.337*−0.381*−0.198*
T1 hypointense lesion volume−0.0080.1470.326*0.1570.1160.0210.138−0.337*0.869*0.366*
T2 hyperintense lesion volume−0.0160.226*0.1860.1160.062−0.0280.090−0.381*0.869*0.098
T1/T2 lesion volume ratio0.1730.0450.331*0.0550.1210.1470.122−0.198*0.366*0.098
Baseline EDSS0.273*0.286*0.424*0.195−0.0620.211−0.219*0.326*0.1860.331*
Age at MRI0.374*0.273*0.153−0.015−0.1620.123−0.370*−0.008−0.0160.173
Disease duration0.374*0.286*0.1970.118−0.0390.170−0.199*0.1470.226*0.045

All correlations are Pearson, except for those involving EDSS which are Spearman; Asterisks indicate p value <0.05

BPV brain parenchymal volume, EDSS expanded disability status scale score

Clinical/MRI multiple sclerosis disease variables in employed vs. not employed patients EDSS Expanded Disability Status Scale score, BPV brain parenchymal volume, LV lesion volume aThis analysis was conducted among patients who reported any of the following: “working for pay,” “temporarily not working but looking for work,” not working or looking for work due to age,” and “not working or looking for work due to disability.” Patients who reported “working for pay” were considered employed. BPV, T1, and T2 lesion volumes are measured in mL b p values were estimated using a non-parametric Wilcoxon rank-sum test for two independent samples cWhen stratified by employment status, the mean age among employed patients was 44.9 (SD 8.6) with a range of 27.1–62.6 years and the mean age among not employed patients was 49.3 (SD 10.5) with a range of 29.8–64.8 years. Note that the regression modeling testing the relationships between MRI and employment status were adjusted for age, sex, and disease duration (see “Results” Section) Clinical subtype of multiple sclerosis by employment status There was no significant difference between employed (n = 76) and not employed (n = 16) groups in terms of the distribution of multiple sclerosis clinical subtype (p > 0.05) Brain atrophy is associated with MS employment status. Boxplot with mean (diamond), median, quartiles, 95 % interval whiskers and outliers. Wilcoxon rank-sum test: p value = 0.036 Brain T1 hypointense lesion volume is associated with MS employment status. Boxplot with mean (diamond), median, quartiles, 95 % interval whiskers and outliers. Wilcoxon rank-sum test: p value = 0.014 Brain T2 hyperintense lesion volume is not associated with MS employment status. Boxplot with mean (diamond), median, quartiles, 95 % interval whiskers and outliers. Wilcoxon rank-sum test: p value = 0.107 Brain T1/T2 lesion volume ratio is associated with MS employment status. Boxplot with mean (diamond), median, quartiles, 95 % interval whiskers and outliers. Wilcoxon rank-sum test: p value = 0.012 Correlations between clinical/MRI multiple sclerosis disease variables and work productivity All correlations are Pearson, except for those involving EDSS which are Spearman; Asterisks indicate p value <0.05 BPV brain parenchymal volume, EDSS expanded disability status scale score

Regression Modeling

To further explore the strength of the relationship between MRI and MS employment status, we developed three logistic regression models (each adjusting for age, sex, and disease duration): (1) T1LV vs. employment status, (2) T1/T2 vs. employment status, and (3) BPV vs. employment status. In the first multivariable logistic regression model, we found a statistically significant reduction (p = 0.047) in the odds of being employed vs. unemployed by 22.4 % for each 1 mL increase in T1LV. We did not observe a significant association between T1/T2 (p = 0.144) or BPV (p = 0.191) and employment status in the second and third multivariable models.

Discussion

The major finding in this study is the increased disease severity as shown by MRI-defined cerebral lesions and atrophy in MS patients who are not employed vs. those who are employed. Among lesion measures, the destructive potential as assessed by the overall T1 hypointense burden and the proportion of T2 hyperintense lesions showing T1 hypointensity were most strongly related to the employment status. In addition, normalized whole brain volume was higher in employed vs. not employed patients, suggesting that brain atrophy was also a factor linked to not employed status. These findings are perhaps not surprising given that a range of neurological and neuropsychological dysfunction in MS, such as physical disability, cognitive impairment, and mood disturbances, have been linked to both impaired work performance [1–4, 6–13] and brain structural damage as defined on MRI scans by lesions and atrophy [22, 32]. Among MRI lesion measures, T1 hypointense lesions have shown both more specificity for destructive irreversible damage [33] and better correlations with mental and physical impairment [24, 34] than T2 hyperintense lesions. These previous studies are in line with our results that T1 hypointense lesions are also more important for employment status than T2 hyperintense lesions. The second major finding was that none of the MRI variables were associated with activity impairment in the whole cohort or any work productivity measures in the employed patients, including overall work impairment, absenteeism, or presenteeism. These aspects of impairment were not common in our sample. Thus, the study may have been underpowered to detect such associations due to the restricted range of activity impairment. Secondly, the latter three measures of impairment are only relevant to employed patients and thus may not have provided sufficient sensitivity. Furthermore, these self-reported measures may not have been reliable. We did not assess any objective measures of productivity while working. Finally, the presence of cognitive reserve [35], which was not assessed in our study, may have provided adaptive ability for patients to maintain function, despite the accumulation of disease-related structural brain changes. A third finding was the strong relationship between physical disability, assessed by EDSS score, and both employment status and activity impairment. Such a relationship has been long known in MS. However, it was striking in our data that EDSS score showed a closer link than the MRI variables to employment and activity impairment. This important role for disability was seen from two perspectives. First, the differences between employed and not employed groups were robust for EDSS (p < 0.001), while less robust for MRI brain atrophy and T1 hypointense lesion variables (p < 0.05). Second, EDSS score, but not MRI variables, showed a significant correlation with activity impairment. One possible explanation for this divergence is the heavy contribution of spinal cord involvement to the EDSS score [26], whereas only brain MRI measures were applied in this study. It is likely that spinal cord involvement, a major contributor to limb and ambulatory disability [29, 36–41], is a key contributor to vocational skills, and is poorly reflected in the level of MRI-defined brain lesions or atrophy in patients with MS [36]. Our cohort was dominated by mildly affected patients with relapsing forms of MS. Given that only 18 % of our patients had progressive forms of MS, further studies are required to assess the link between brain MRI findings and employment in advanced forms of the disease. Sample size should also be taken into account as the not employed group comprised 16 patients. We are now planning to study larger cohorts. Additional work is necessary to establish whether the relationships between MRI and employment are independent from the effects of cognitive impairment and fatigue. Because of sample size and the restricted range of employment impairment, there may have been limited power to detect the full extent of MRI relationships. It would be of interest for future studies to test whether other aspects of MRI-defined involvement in MS, such as spinal cord [36-41], cortical [42, 43], and diffuse cerebral damage [44-46], are related to productivity and whether MRI findings predict longitudinal change of employment status. Destructive effects of lesions may be particularly prominent using ultra-high-field strength MRI [47]. In summary, our study demonstrates a clear relationship between brain MRI and employment status in MS.
  47 in total

Review 1.  Sodium imaging as a marker of tissue injury in patients with multiple sclerosis.

Authors:  M Inglese; N Oesingmann; W Zaaraoui; J P Ranjeva; L Fleysher
Journal:  Mult Scler Relat Disord       Date:  2013-05-03       Impact factor: 4.339

2.  Demographic and clinical factors associated with changes in employment in multiple sclerosis.

Authors:  Phil Moore; Katharine E Harding; Hannah Clarkson; Trevor P Pickersgill; Mark Wardle; Neil P Robertson
Journal:  Mult Scler       Date:  2013-05-07       Impact factor: 6.312

3.  Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

Authors:  L Truyen; J H van Waesberghe; M A van Walderveen; B W van Oosten; C H Polman; O R Hommes; H J Adèr; F Barkhof
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

4.  Predicting employment status in multiple sclerosis patients: the utility of the MS functional composite.

Authors:  Kimia Honarmand; Nadine Akbar; Nancy Kou; Anthony Feinstein
Journal:  J Neurol       Date:  2010-09-12       Impact factor: 4.849

5.  Multitasking in multiple sclerosis: can it inform vocational functioning?

Authors:  Chelsea L Morse; Maria T Schultheis; Joshua D McKeever; Thomas Leist
Journal:  Arch Phys Med Rehabil       Date:  2013-08-04       Impact factor: 3.966

6.  Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling.

Authors:  Stefan M Gold; Mary-Frances O'Connor; Raja Gill; Kyle C Kern; Yonggang Shi; Roland G Henry; Daniel Pelletier; David C Mohr; Nancy L Sicotte
Journal:  Hum Brain Mapp       Date:  2012-07-30       Impact factor: 5.038

7.  Brain atrophy and lesion load predict long term disability in multiple sclerosis.

Authors:  Veronica Popescu; Federica Agosta; Hanneke E Hulst; Ingrid C Sluimer; Dirk L Knol; Maria Pia Sormani; Christian Enzinger; Stefan Ropele; Julio Alonso; Jaume Sastre-Garriga; Alex Rovira; Xavier Montalban; Benedetta Bodini; Olga Ciccarelli; Zhaleh Khaleeli; Declan T Chard; Lucy Matthews; Jaqueline Palace; Antonio Giorgio; Nicola De Stefano; Philipp Eisele; Achim Gass; Chris H Polman; Bernard M J Uitdehaag; Maria Jose Messina; Giancarlo Comi; Massimo Filippi; Frederik Barkhof; Hugo Vrenken
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-23       Impact factor: 10.154

8.  Spinal cord gray matter atrophy correlates with multiple sclerosis disability.

Authors:  Regina Schlaeger; Nico Papinutto; Valentina Panara; Carolyn Bevan; Iryna V Lobach; Monica Bucci; Eduardo Caverzasi; Jeffrey M Gelfand; Ari J Green; Kesshi M Jordan; William A Stern; H-Christian von Büdingen; Emmanuelle Waubant; Alyssa H Zhu; Douglas S Goodin; Bruce A C Cree; Stephen L Hauser; Roland G Henry
Journal:  Ann Neurol       Date:  2014-08-21       Impact factor: 10.422

Review 9.  Cognitive reserve in multiple sclerosis.

Authors:  James F Sumowski; Victoria M Leavitt
Journal:  Mult Scler       Date:  2013-08       Impact factor: 6.312

10.  Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale.

Authors:  Rohit Bakshi; Mohit Neema; Brian C Healy; Zsuzsanna Liptak; Rebecca A Betensky; Guy J Buckle; Susan A Gauthier; James Stankiewicz; Dominik Meier; Svetlana Egorova; Ashish Arora; Zachary D Guss; Bonnie Glanz; Samia J Khoury; Charles R G Guttmann; Howard L Weiner
Journal:  Arch Neurol       Date:  2008-11
View more
  6 in total

1.  Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.

Authors:  Keren Regev; Brian C Healy; Fariha Khalid; Anu Paul; Renxin Chu; Shahamat Tauhid; Subhash Tummala; Camilo Diaz-Cruz; Radhika Raheja; Maria A Mazzola; Felipe von Glehn; Pia Kivisakk; Sheena L Dupuy; Gloria Kim; Tanuja Chitnis; Howard L Weiner; Roopali Gandhi; Rohit Bakshi
Journal:  JAMA Neurol       Date:  2017-03-01       Impact factor: 18.302

2.  Occupational outcomes of people with multiple sclerosis: a scoping review.

Authors:  Bruno Kusznir Vitturi; Alborz Rahmani; Guglielmo Dini; Alfredo Montecucco; Nicoletta Debarbieri; Elvira Sbragia; Paolo Bandiera; Michela Ponzio; Mario Alberto Battaglia; Tommaso Manacorda; Benedetta Persechino; Giuliana Buresti; Matilde Inglese; Paolo Durando
Journal:  BMJ Open       Date:  2022-07-01       Impact factor: 3.006

3.  A dual modeling approach to automatic segmentation of cerebral T2 hyperintensities and T1 black holes in multiple sclerosis.

Authors:  Alessandra M Valcarcel; Kristin A Linn; Fariha Khalid; Simon N Vandekar; Shahamat Tauhid; Theodore D Satterthwaite; John Muschelli; Melissa Lynne Martin; Rohit Bakshi; Russell T Shinohara
Journal:  Neuroimage Clin       Date:  2018-10-16       Impact factor: 4.881

4.  TAPAS: A Thresholding Approach for Probability Map Automatic Segmentation in Multiple Sclerosis.

Authors:  Alessandra M Valcarcel; John Muschelli; Dzung L Pham; Melissa Lynne Martin; Paul Yushkevich; Rachel Brandstadter; Kristina R Patterson; Matthew K Schindler; Peter A Calabresi; Rohit Bakshi; Russell T Shinohara
Journal:  Neuroimage Clin       Date:  2020-05-16       Impact factor: 4.881

5.  Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study.

Authors:  Cecilie Jacobsen; Robert Zivadinov; Kjell-Morten Myhr; Turi O Dalaker; Ingvild Dalen; Niels Bergsland; Elisabeth Farbu
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-01-27

6.  Correlation between the clinical disability and T1 hypointense lesions' volume in cerebral magnetic resonance imaging of multiple sclerosis patients: A systematic review and meta-analysis.

Authors:  Amir Valizadeh; Mana Moassefi; Elham Barati; Mohammad Ali Sahraian; Faezeh Aghajani; Mohammad-Reza Fattahi
Journal:  CNS Neurosci Ther       Date:  2021-10-03       Impact factor: 5.243

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.